22 Dec 2021

Grace Pharmaceutical Solutions Brochure

PDF 22.2 MB

Learn more about Grace's unmatched quality and reproducibility of our fine chemicals, chromatography resins, formulation excipients, and active ingredient delivery technologies.

Content provided by our supplier

W. R. Grace & Co

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
Company types

Other Content from W. R. Grace & Co (1)

  • News Grace Completes Acquisition of Fine Chemistry Business

    June 01, 2021: W. R. Grace & Co. announced the completion of its acquisition of the Fine Chemistry Services business (“FCS”) of Albemarle Corporation (NYSE: ALB) for approximately $570 million, including $300 million paid in cash and $270 million funded through the issuance to Albemarle of non-participating preferred equity of a newly created Grace subsidiary.